Long-term outcomes of hypofractionated stereotactic radiotherapy for refractory functional pituitary adenoma

ConclusionHSRT for refractory pituitary adenoma is well-tolerated with long-term local and biochemical control comparable with single-fraction SRS or IMRT. Prospective studies should evaluate whether HSRT provides non-inferior biochemical control and improved toxicity compared with single-fraction SRS.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research